Latest pancreatic cancer News

First Turkish patient treated with OncoSil cancer treatment device
Cancer Research KI network support translational collaboration in molecular mechanisms at Schulte lab
Tour de Cure grant for brain cancer research
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccine
Can4Cancer pedals towards $20 million raised for cancer research
Pancreatic Cancer Rising In Younger People
New data shows top five cancers projected to affect people in Nepean Blue Mountains Local Health District
Raising our voices for better palliative care
UNSW researchers receive more than $20m in Ideas and Development Grants
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
November is Pancreatic Cancer Awareness Month
$5 million NHMRC funding for cancer research
Mater Researcher shares in $1.8 million to fight one of Australia’s deadliest cancers
National register to help fight pancreatic cancer
Landmark blood test to detect silent, lethal cancer
Walk4Rita helps in pancreatic cancer fight
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
From warzone doctor to Geelong surgeon
November is Pancreatic Cancer Awareness Month
Imugene says next cohort reached in intravenous arms of monotherapy and combination study
Raising Pancreatic Cancer Awareness in November
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Important workers compensation reforms supporting fire-fighters pass Parliament
Arovella Therapeutics licences monoclonal antibody for cell therapy development
US FDA grants Orphan Drug Designation for Noxopharm’s CRO-67
Progressing nation-leading reforms for our firefighters
Leading the way in health and safety for Tasmania’s fire-fighters
Pharmaxis announces the publication of positive preclinical data for PXS-5505
Drug that targets scar-like tissue in tumours shows promise for pancreatic cancer
Drug that targets scar-like tissue in tumours shows promise
6 things to know about pancreatic cancer 18 August
Gene-editing tool helps target small cancer-linked mutations
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Surviving lung cancer is just beginning
NSW new $25 million boost to support those living with hard-to-treat cancers
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
$25 million boost to support those living with hard to treat cancers 
Firefighter cancer scheme would be expanded under Greens’ bill
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Cancers in distant organs alter liver function
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023